Mydriasis due to self-administered inhaled ipratropium bromide.
Mydriasis due to ipratropium bromide has previously been described in children and adults. Children as young as 4 years of age may attempt to self-administer their inhalers. This possibility should be considered if an asthmatic child presents with abnormal neurological signs.